Emergent BioSolutions (EBS) Curent Deferred Tax Liability (2013 - 2014)
Emergent BioSolutions (EBS) recorded quarterly Curent Deferred Tax Liability of $88000.0 in Q3 2014, little changed quarter-over-quarter from $88000.0 in Q2 2014.
Emergent BioSolutions (EBS) Curent Deferred Tax Liability (2013 - 2014) Analysis & Trends
Emergent BioSolutions' Curent Deferred Tax Liability history runs 2 years deep, the most recent figure standing at $88000.0 for Q3 2014.
- In Q3 2014, Curent Deferred Tax Liability changed N/A year-over-year to $88000.0; the TTM figure through Sep 2014 stood at $88000.0 (changed N/A YoY), while the FY2013 annual figure was $88000.0, changed N/A from the prior year.
- Curent Deferred Tax Liability was $88000.0 for Q3 2014 at Emergent BioSolutions, roughly flat from $88000.0 in the prior quarter.
- In the past five years, Curent Deferred Tax Liability ranged from a high of $88000.0 in Q4 2013 to a low of $88000.0 in Q4 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Curent Deferred Tax (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | Emergent BioSolutions | 415.46 Mn | 253.96 Mn | 84.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2014 | 88,000.00 |
| Sep 30, 2014 | 88,000.00 |
| Jun 30, 2014 | 88,000.00 |
| Jun 30, 2014 | 88,000.00 |
| Mar 31, 2014 | 88,000.00 |
| Mar 31, 2014 | 88,000.00 |
| Dec 31, 2013 | 88,000.00 |
| Dec 31, 2013 | 88,000.00 |